🇺🇸 FDA
Pipeline program

TEV-56286

TV56286-NDG-20041

Phase 2 small_molecule active

Quick answer

TEV-56286 for Multiple System Atrophy is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Multiple System Atrophy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials